Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-016074

Director sold 59,240 shares at an average $12.50 ($740,658)

  • Director acquired 156,679 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal Director 2023-03-01 Option exercise +96,150 1,271,913 D
Walker Neal Director 2023-03-01 Option exercise +18,275 1,290,188 D
Walker Neal Director 2023-03-01 Option exercise +24,000 1,314,188 D
Walker Neal Director 2023-03-02 Sale −29,000 $12.37 $358,588 1,285,188 D
Walker Neal Director 2023-03-02 Option exercise +18,254 1,303,442 D
Walker Neal Director 2023-03-03 Sale −30,240 $12.63 $382,070 1,273,202 D
Derivatives
Walker Neal Director 2023-03-01 Option exercise · Restricted Stock Units −96,150 0 D
Walker Neal Director 2023-03-01 Option exercise · Restricted Stock Units −18,275 36,550 D
Walker Neal Director 2023-03-01 Option exercise · Restricted Stock Units −24,000 72,000 D
Walker Neal Director 2023-03-02 Option exercise · Restricted Stock Units −18,254 18,254 D
Open-market sales · 59,240 sh · avg $12.50 · $740,658
Loading xslF345X03/doc4.xml…